Recent News for FGEN - FibroGen, Inc

Date Title
Oct 16 5 Stocks With High Net Income Ratio to Scoop Up
Oct 11 Roxadustat Global Phase 3 Results for Treatment of Chronic Kidney Disease (CKD) Anemia to be Presented at American Society of Nephrology Kidney Week 2019
Oct 7 FibroGen Congratulates Dr. William G. Kaelin, Jr., Scientific Advisory Board Member, on Receipt of the 2019 Nobel Prize in Physiology or Medicine
Oct 7 UK and US scientists win Nobel Medicine Prize
Oct 3 FibroGen Enters Oversold Territory
Oct 3 Heron Therapeutics (HRTX) Catches Eye: Stock Jumps 6.2%
Oct 1 FibroGen Receives One of China Pharmaceutical Industry’s Highest Awards for Clinical Innovation for Roxadustat
Sep 30 FibroGen Announces Publication in the Lancet Respiratory Medicine of Positive Pamrevlumab Efficacy and Safety Data for the Praise Phase 2 Study in Idiopathic Pulmonary Fibrosis
Sep 27 FibroGen Begins Study on Roxadustat for Chemo-Induced Anemia
Sep 26 Tyme Initiates Pivotal Stage of Pancreatic Cancer Study
Sep 26 BioLineRx Begins Part 2 of Phase I/IIa Study on Solid Tumors
Sep 26 FibroGen launches mid-stage study of roxadustat in chemo-induced anemia
Sep 26 FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment of Anemia in Cancer Patients Receiving Chemotherapy
Sep 25 Dova Pharmaceuticals (DOVA) Jumps: Stock Rises 8.8%
Sep 23 Aerie Secures Positive CHMP Opinion for Eye Drug Rhokiinsa
Sep 23 Zoetis (ZTS) Receives EC Approval for Simparica Trio in Dogs
Sep 20 FibroGen's Evrenzo Gets Nod in Japan for Anemia with CKD
Sep 20 The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering
Sep 20 Astellas Pharma and FibroGen's roxadustat OK'd in Japan
Sep 20 Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
Sep 20 Evrenzo® (roxadustat) Tablets Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
Sep 18 Is FibroGen, Inc.'s (NASDAQ:FGEN) 7.6% ROE Worse Than Average?
Sep 13 Zacks.com featured highlights include: ACM, FibroGen, Funko, Matrix Service and PetIQ
Sep 12 What Makes Crinetics Pharmaceuticals (CRNX) a Strong Sell?
Sep 12 5 Stocks with High Net Income Ratio to Grab Now
Back to the Main FGEN Page...